Merck (NYSE:MRK) announced topline results from the pivotal Phase 2b/3 BRUNELLO trial evaluating remigromig (MK-3000, formerly EYE103) in adults with diabetic macular edema (DME).
Eli Lilly (NYSE:LLY) received U.S. Food and Drug Administration approval on September 24, 2026, for Onswik, a once-weekly basal insulin treatment for adults with type 2 diabetes.
Biodesix (NASDAQ:BDSX) announced progress on two molecular residual disease (MRD) testing programs designed to detect circulating tumor DNA (ctDNA) in blood samples following cancer treatment.
Vertiv (NYSE:VRT) agreed on September 24, 2026, to acquire King Environmental Services (KES), a Europe-based provider of fluid-management services for data centers and critical infrastructure applications.
Fervo Energy (NYSE:FRVO) announced that its Cape Station geothermal project in Utah achieved First Power on September 24, 2026, marking the start of electricity exports from the facility.
Sequans Communications (NYSE:SQNS) completed the sale of its remaining 314 Bitcoin holdings, ending its Bitcoin treasury strategy and refocusing on its semiconductor business.
MediciNova (NASDAQ:MNOV) announced the completion of the last patient’s final visit in the double-blind portion of its Phase 2b/3 COMBAT-ALS trial evaluating MN-166 (ibudilast) for amyotrophic lateral sclerosis (ALS).
aTyr Pharma (NASDAQ:ATYR) announced FDA alignment on the planned Phase 3 study protocol for efzofitimod in patients with pulmonary sarcoidosis on September 24, 2026.
Kyverna Therapeutics (NASDAQ:KYTX) reported updated clinical data for its investigational CAR-T therapy miv-cel (mivocabtagene autoleucel) in stiff person syndrome (SPS) and generalized myasthenia gravis (gMG).
RTX (NYSE:RTX) and United Airlines marked the delivery of the first Airbus A321XLR aircraft powered by Pratt & Whitney’s GTF Advantage engine on September 24, 2026.
GARANTA JÁ SEU GRAFA EDGE
Vamos ativar um teste de 30 dias do Edge como presente de boas-vindas
